Metalloproteinases and Hypertrophic Cardiomyopathy: A Systematic Review
DAVIDE COSTA
Biomolecules
View PDFchevron_right
Matrix Metalloproteinases Repress Hypertrophic Growth in Cardiac Myocytes
Péter Bencsik
Cardiovascular Drugs and Therapy
View PDFchevron_right
Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia
Mark Alexander
Circulation. Heart failure, 2012
View PDFchevron_right
Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes
Andreas Kalogeropoulos, Christine Staercke
International Journal of Cardiology, 2011
View PDFchevron_right
Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: A marker of cardiac dilatation
Hanumanth Reddy
Molecular and Cellular Biochemistry, 2005
View PDFchevron_right
Increased cardiac mRNA expression of matrix metalloproteinase-1 (MMP–1) and its inhibitor (TIMP–1) in DCM patients
Michael Fassbach
Clinical Research in Cardiology, 2006
View PDFchevron_right
Myocardial Collagen Turnover in Hypertrophic Cardiomyopathy
Quirino Ciampi
Circulation, 2003
View PDFchevron_right
Matrix metalloproteinase (MMP)-9: A proximal biomarker for cardiac remodeling and a distal biomarker for inflammation
Merry Lindsey
Pharmacology & Therapeutics, 2013
View PDFchevron_right
Immunoexpression of MMP-8, MMP-9 and TIMP-2 in dilated cardiomyopathy
Claudiu Margaritescu
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2019
View PDFchevron_right
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats
Yasuki Kihara
Journal of the American College of Cardiology, 2002
View PDFchevron_right
Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression
Sawa Kostin
Journal of The American College of Cardiology, 2004
View PDFchevron_right
Collagen I and III, MMP-1 and TIMP-1 immunoexpression in dilated cardiomyopathy
Alexandru mihailovici
Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie, 2017
View PDFchevron_right
The role of matrix metalloproteinases in heart disease
Jack Cleutjens
Cardiovascular Research, 1996
View PDFchevron_right
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure
Gad Keren, David Sheps
American Heart Journal, 2005
View PDFchevron_right
Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure
Hussein Hallak
Circulation Research, 1999
View PDFchevron_right
Cardiac Restricted Overexpression of Membrane Type-1 Matrix Metalloproteinase Causes Adverse Myocardial Remodeling following Myocardial Infarction
Lawrence W Dobrucki
Journal of Biological Chemistry, 2010
View PDFchevron_right
Non-invasive evaluation of myocardial fibrosis: implications for the clinician
Per Lav Madsen
Heart, 2010
View PDFchevron_right
Matrix metalloproteinase gene polymorphisms in heart failure: new pieces to the myocardial matrix puzzle
Marco Antonio Rosa
European Heart Journal, 2004
View PDFchevron_right
Role of extracellular matrix metalloproteinases in cardiac remodelling
Hanumanth Reddy
Heart Failure Reviews, 1996
View PDFchevron_right
Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction
Jamie Crawford
Circulation, 2002
View PDFchevron_right
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure
Lee Jackson
Journal of cardiac …, 2002
View PDFchevron_right
Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling
C. McTiernan
Cardiovascular Research, 2000
View PDFchevron_right
Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis
Vera Regitz-Zagrosek
Journal of Molecular Medicine, 2004
View PDFchevron_right
Expression and Complex Formation of MMP9, MMP2, NGAL, and TIMP1 in Porcine Myocardium but Not in Skeletal Muscles in Male Pigs with Tachycardia-Induced Systolic Heart Failure
Agnieszka Noszczyk-Nowak
BioMed Research International, 2013
View PDFchevron_right
Matrix Metalloproteinases in Myocardial Infarction and Heart Failure
Cesar A Meschiari
Progress in molecular biology and translational science, 2017
View PDFchevron_right
Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents
Roberto Hernandez-Merlo
American journal of physiology. Heart and circulatory physiology, 2018
View PDFchevron_right
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction
sohail khan
View PDFchevron_right
Cardiac-Restricted Overexpression of Membrane Type1 Matrix Metalloproteinase in Mice Effects on Myocardial Remodeling With Aging
Christy Beck
View PDFchevron_right
Disruption of the myocardial extracellular matrix leads to cardiac dysfunction
Erik Young
Journal of Clinical Investigation, 2000
View PDFchevron_right
Clinical significance of matrix metalloproteinase (MMP)-2 in patients with acute heart failure
Dimitris Papadopoulos
2010
View PDFchevron_right